Practice Areas - Debt Capital Markets Law Firms and Lawyers
| Deal Date: | 08-03-2016 | Practice Area: | Debt Capital Markets |
| Deal Title: | Amgen Regulation S Offering of CHF Notes due 2023 | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Shearman and Sterling represented UBS AG, BNP Paribas (Suisse) SA and Credit Suisse AG in connection with Amgen Inc.'s Regulation S offering of CHF 700 million aggregate principal amount of 0.410% notes due 2023. Amgen is a global biotechnology company that discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.
|
||
| Financial Center: | San Francisco | Value: | 500.01-1000.00 |
| Advised Party: | Lead Manager | Law Firm | Shearman & Sterling |
| Issuer Jurisdiction | United States | Listing Jurisdiction | United States |
| Classification: |
Corporate Bonds Senior Debt |
Lawyer | John D Wilson |
